About this trial
The goal of this study is to understand and improve the breast surgical decision-making process for young women newly diagnosed with breast cancer. As part of this study, the investigators will evaluate the impact and use a web-based tool called CONSYDER that is designed to provide useful information to young breast cancer patients. It is also meant to improve communication between young women and their surgeons with the purpose of helping patients make appropriate surgical decisions.
Participants will complete surveys approximately within 1 week of the surgical consult and approximately 6 months after surgery. Patients who receive neoadjuvant chemotherapy will also be surveyed after the completion of neoadjuvant treatment but prior to surgery. Some patients will be invited for an interview after their surgery as part of the evaluation. A subset of patients/surgeons will also have their surgical consultation audio-recorded.
Eligibility criteria
Qualifiers
Female aged 18-44
New diagnosis of Stage 0, 1, 2, or 3 unilateral breast cancer
English or Spanish speaking
Disqualifiers
Diagnosis of de novo Stage 4 breast cancer
Recurrent early-stage breast cancer
Bilateral breast cancer
Trial design
Treatments tested in this trial
- CONSYDER decision aid
Treatment groups
Sponsors and collaborators
Weill Medical College of Cornell University
Lead sponsor
National Institutes of Health (NIH)
Collaborator
National Cancer Institute (NCI)
Collaborator